{"id":2015190,"date":"2023-08-29T08:23:01","date_gmt":"2023-08-29T12:23:01","guid":{"rendered":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/cms-names-10-drugs-under-new-price-controls-but-advocates-warn-of-cruel-side-effects\/"},"modified":"2023-08-29T08:25:10","modified_gmt":"2023-08-29T12:25:10","slug":"cms-names-10-drugs-under-new-price-controls-but-advocates-warn-of-cruel-side-effects","status":"publish","type":"post","link":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/cms-names-10-drugs-under-new-price-controls-but-advocates-warn-of-cruel-side-effects\/","title":{"rendered":"CMS announces 10 drugs under new price controls, advocates caution against &#8216;cruel&#8217; consequences."},"content":{"rendered":"<aside class=\"mashsb-container mashsb-main mashsb-stretched\"><div class=\"mashsb-box\"><div class=\"mashsb-count mash-medium\" style=\"&quot;\"><div class=\"counts mashsbcount\">26<\/div><span class=\"mashsb-sharetext\">SHARES<\/span><\/div><div class=\"mashsb-buttons\"><a class=\"mashicon-facebook mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.conservativenewsdaily.net%2Fbreaking-news%2Fcms-names-10-drugs-under-new-price-controls-but-advocates-warn-of-cruel-side-effects%2F\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Facebook<\/span><\/a><a class=\"mashicon-twitter mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/twitter.com\/intent\/tweet?text=&amp;url=https:\/\/www.conservativenewsdaily.net\/breaking-news\/?p=2015190&amp;via=ConservNewsDly\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Twitter<\/span><\/a><a class=\"mashicon-subscribe mash-medium mash-nomargin mashsb-noshadow\" href=\"#\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Subscribe<\/span><\/a><div class=\"onoffswitch2 mash-medium mashsb-noshadow\" style=\"display:none\"><\/div><\/div>\n            <\/div>\n                <div style=\"clear:both\"><\/div><\/aside>\n            <!-- Share buttons by mashshare.net - Version: 4.0.47--><h2>The Centers \u2062for Medicare and Medicaid Services Announce Drug Price Negotiation\u2063 Program<\/h2>\n<p>The Centers for Medicare and Medicaid Services (CMS)\u2062 has \u2063recently unveiled the list of 10 medications that will be included in the groundbreaking Drug Price Negotiation Program. This program, \u2062established through the Inflation Reduction Act,\u2063 is set to impact an estimated 9.7 million patients suffering from various illnesses such as heart failure, blood clots, diabetes, and arthritis.<\/p>\n<blockquote>\n<p>&#8220;For\u200b far too long, pharmaceutical \u2063companies have prioritized their profits over the well-being of\u2064 American families. The exorbitant prices of life-saving prescription drugs have\u200b left many unable to afford \u2062the treatment they desperately\u2062 need. However, thanks\u2064 to the Inflation\u200d Reduction Act, we are now\u200d one step\u2063 closer to achieving President Biden&#8217;s\u200c vision of increased accessibility and reduced costs for prescription drugs,&#8221;<\/p>\n<p>said\u200b Secretary of\u2063 Health \u2063and Human Services, Xavier \u200dBecerra.<\/p>\n<\/blockquote>\n<h3>Impact on Patients and\u200d Medications<\/h3>\n<p>The list of medications includes some of the most expensive\u200c drugs on the market, such as Eliquis, used to prevent blood clots,\u200d and Jardiance, prescribed for \u200cdiabetes and heart failure.\u2063 Other medications \u200don the list include Xarelto, Januvia, Farxiga,\u200c Entresto, \u200bEnbrel,\u2062 Imbruvica, Stelara, as well as \u2064various\u200c products associated with diabetes medications Fiasp and \u2062NovoLog.<\/p>\n<p>According \u200dto the HHS, these ten drugs accounted for a staggering \u200c$50.5 billion \u200din \u200dMedicare Part D spending between June 2022 and May 2023, representing approximately 20% of the total Part D <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/cms-names-10-drugs-under-new-price-controls-but-advocates-warn-of-cruel-side-effects\/\" title=\"CMS announces 10 drugs under new price controls, advocates caution against 'cruel' consequences.\">gross covered prescription drug costs<\/a>.<\/p>\n<h3>The Negotiation\u200d Process and Future Plans<\/h3>\n<p>The \u2064Inflation Reduction Act grants the HHS secretary the authority to negotiate a \u2062<a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/law-allowing-for-government-negotiation-with-drug-firms-on-prices-is-troubled\/\" title=\"Troubles arise with law permitting government 'negotiation' on drug prices.\">maximum fair price<\/a> for Medicare Part D coverage of expensive medications without generic or biologic alternatives. Secretary Becerra will finalize the first round of <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/not-just-climate-inflation-reduction-act-has-made-major-healthcare-changes-one-year-in\/\" title=\"Inflation Reduction Act brings significant healthcare changes after one year.\">maximum fair prices<\/a> by September\u2064 2024, and they will go \u2062into effect in the market starting from \u20642026.<\/p>\n<p>Looking ahead, by 2029, the HHS plans to expand \u2062the \u200cnegotiation program to include 20 drugs applicable to both Medicare Parts B and D.<\/p>\n<h3>Concerns and Perspectives<\/h3>\n<p>While the price \u2063controls\u200d on\u2063 medications aim to benefit many patients, there are concerns \u2063about the potential \u200cnegative impact on those with rare\u2062 conditions. The costs associated \u200dwith treating \u200bthese conditions are often offset by patients who use less expensive drugs for \u2062more common illnesses.<\/p>\n<p>Tom Schatz, president of Citizens Against\u200b Government Waste, warns that the IRA&#8217;s \u2064Medicare pricing\u200d provision has already hindered pharmaceutical research, potentially depriving\u2064 patients \u2063of new life-saving \u200ddrugs. He\u2063 emphasizes the importance \u200bof allowing pharmaceutical manufacturers to\u200d recover their investments, even for drugs \u200cthat do\u200b not \u200creach\u2062 the\u2062 market.<\/p>\n<p>On \u200dthe other hand, patient advocate John &#8220;CZ&#8221; Czwartacki, founder and \u200dchairman of \u2063Survivors For Solutions, credits government support for innovation in helping\u200b find a cure for multiple sclerosis (MS). He believes that the IRA&#8217;s disincentives would have hindered the development of \u200dthe \u2063treatments he needed, ultimately impacting his quality of life.<\/p>\n<p>For individuals battling complex and rare\u200c diseases like\u200b MS, Czwartacki argues that the <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/where-three-key-policy-proposals-in-the-inflation-reduction-act-stand-one-year-later\/\" title=\"One year later, the status of three key policy proposals in the Inflation Reduction Act.\">price\u200d negotiation program<\/a> will hinder their access to vital\u200c treatments, reducing the pipeline of innovative solutions.<\/p>\n<p>In\u200b conclusion, while the \u200dDrug Price Negotiation Program aims to address the issue\u2062 of skyrocketing drug prices, it is\u2064 crucial to consider the potential consequences\u200c for patients with rare conditions. Striking a balance \u200bbetween \u2062affordability \u2063and innovation remains a challenge that \u2064policymakers \u2062must navigate.<\/p>\n<p><a href=\"https:\/\/www.washingtonexaminer.com\">Click here<\/a> to read more\u2063 from the Washington \u200bExaminer.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Centers for Medicare and Medicaid Services unveiled the Drug Price Negotiation Program&#8217;s medication list, impacting around 9.7 million patients with various conditions like heart failure, blood clots, diabetes, and arthritis. This move, facilitated by the Inflation Reduction Act, aims to address the prolonged issue of high pharmaceutical prices.<\/p>\n","protected":false},"author":1,"featured_media":2015191,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","fifu_image_alt":"","footnotes":""},"categories":[538],"tags":[],"class_list":["post-2015190","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-washington-examiner"],"fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","_links":{"self":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2015190","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/comments?post=2015190"}],"version-history":[{"count":0,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2015190\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media\/2015191"}],"wp:attachment":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media?parent=2015190"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/categories?post=2015190"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/tags?post=2015190"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}